Airway surface liquid depth measured in ex vivo fragments of pig and human trachea: dependence on Na+ and Cl- channel function - PubMed (original) (raw)
Airway surface liquid depth measured in ex vivo fragments of pig and human trachea: dependence on Na+ and Cl- channel function
Yuanlin Song et al. Am J Physiol Lung Cell Mol Physiol. 2009 Dec.
Abstract
The airway surface liquid (ASL) is the thin fluid layer lining the airways whose depth may be reduced in cystic fibrosis. Prior measurements of ASL depth have been made in airway epithelial cell cultures. Here, we established methodology to measure ASL depth to approximately 1-microm accuracy in ex vivo fragments of freshly obtained human and pig tracheas. Airway fragments were mounted in chambers designed for perfusion of the basal surface and observation of the apical, fluorescently stained ASL by scanning confocal microscopy using a high numerical aperture lens immersed in perfluorocarbon. Measurement accuracy was verified using standards of specified fluid thickness. ASL depth in well-differentiated primary cultures of human nasal respiratory epithelium was 8.0 +/- 0.5 microm (SE 10 cultures) under basal conditions, 8.4 +/- 0.4 microm following ENaC inhibition by amiloride, and 14.5 +/- 1.2 microm following CFTR stimulation by cAMP agonists. ASL depth in human trachea was 7.0 +/- 0.7 microm under basal conditions, 11.0 +/- 1.7 microm following amiloride, 17.0 +/- 3.4 microm following cAMP agonists, and 7.1 +/- 0.5 microm after CFTR inhibition. Similar results were found in pig trachea. This study provides the first direct measurements of ASL depth in intact human airways and indicates the involvement of ENaC sodium channels and CFTR chloride channels in determining ASL depth. We suggest that CF lung disease may be caused by the inability of CFTR-deficient airways to increase their ASL depth transiently following secretory stimuli that in non-CF airways produce transient increases in ASL depth.
Figures
Fig. 1.
Methodology for measurement of airway surface liquid (ASL) thickness (ASL depth). A: schematic of perfusion chamber showing a cell layer/tissue fragment with mucosal surface facing upward. The mucosal ASL is covered with a high-boiling point perfluorocarbon and visualized from above using a high-numerical aperture immersion lens. The basal, downward-facing surface is exposed to perfusate. B: photograph of perfusion chamber (from above). C: thickness measurements in solution standards consisting of specified volumes of PBS containing rhodamine B-dextran between 2 cover glasses to give fluid thicknesses of 4, 5, 6, 10, and 20 μm. The 0-μm sample consists of a dried thin fluorescent film in place of the fluorescent solution. Left: representative x-z confocal reconstructions. Right: fluorescence intensity profiles in the _z_-direction, showing 10 profiles at different _x,y_-positions overlaid for each solution thickness. The horizontal dashed line drawn at 70% of maximum fluorescence was used as a threshold to define boundaries of the fluorescent solution layers. D: histograms of number vs. _z_-depth determined from data as in C. ASL depths were binned in 0.01-μm intervals for histogram construction.
Fig. 2.
ASL depth measurements in well-differentiated human airway epithelial cell cultures grown on porous supports. A: hematoxylin and eosin staining of non-CF and CF nasal respiratory cell cultures. B: Ussing chamber measurements of short-circuit current in response to ENaC inhibition (amiloride, 10 μM), CFTR activation (forskolin, 10 μM) and inhibition (CFTRinh-172, 10 μM), and calcium-activated chloride channel activation (UTP, 100 μM) and inhibition (CaCCinh-01, 30 μM). C, left: representative x-z confocal reconstructions shown together with _z_-fluorescence profiles for nasal respiratory cell cultures. The ASL was stained red with rhodamine B-dextran and surface epithelial cells green with Cell Track Green. Channel activators/inhibitors were present in culture medium for 4 h as indicated: 100 μM amiloride, 20 μM CFTRinh-172, 100 μM IBMX, 20 μM forskolin. Ten _z_-fluorescence profiles overlaid for each condition. Right: number vs. _z_-depth histograms. D, top: average ASL depths (means ± SE, n = 4–8 cultures/condition). *P < 0.05 between non-CF and CF cultures for basal ASL depth; #P < 0.02 for basal vs. forskolin/IBMX-treated cultures; **P < 0.05 for amiloride-treated non-CF vs. CF cultures. Bottom: time course of ASL depth in non-CF cultures following addition of IBMX and forskolin to the perfusate.
Fig. 3.
ASL depth measurements in pig trachea. A, left: hematoxylin/eosin staining of whole pig trachea. Right: staining of the posterior membranous region of trachea that is devoid of cartilaginous rings. B: short-circuit analysis. ENaC and CFTR modulators added where indicated: 100 μM amiloride, 20 μM forskolin, 100 μM IBMX, 20 μM MalH-2. C: photograph of perfusion chamber containing tracheal fragment surrounded by temperature controller. D: time course of ASL depth in pig trachea following addition of 20 μl of fluid on the mucosa (SE, n = 3). E, left: representative x-z confocal reconstructions and _z_-fluorescence profiles. Right: number vs. ASL depth histograms for measurements on different pig tracheas.
Fig. 4.
ASL depth measurements in human trachea. A: hematoxylin and eosin staining of human tracheal mucosa. B: short-circuit analysis showing effects of ENaC and CFTR modulators added where indicated: 100 μM amiloride, 20 μM forskolin, 100 μM IBMX, 20 μM CFTRinh-172. C, left: representative x-z confocal reconstructions and _z_-fluorescence profiles. Right: number vs. ASL depth histograms for measurements on different human tracheas.
Fig. 5.
Effect of Na+ and Cl− channel modulators on ASL depth in pig and human trachea. A and B: measurements made on pig (A) and human (B) tracheal fragments in which the mucosa was incubated at 37°C for 6 h without or with amiloride (100 μM), forskolin (20 μM), IBMX (100 μM), MalH-2 (20 μM), or CFTRinh-172 (20 μM). Left: representative x-z confocal fluorescence reconstructions. Right: number vs. ASL depth histograms. C and D: summary of ASL depths (means ± SE, n = 3–6) in pig trachea (C) and human trachea (D). *P < 0.05 compared with control.
Fig. 6.
Effect of amiloride and CFTR activators on steady-state ASL depth in pig trachea. A: the ASL was initially allowed to reach steady-state depth by 6-h incubation at 37°C in the absence of modulators. Amiloride or forskolin/IBMX were then applied as described in
methods
, and ASL depth was measured 2 h later (means ± SE, n = 4–5). Control indicates no modulator added. *P < 0.05 compared with control. B: control study showing amiloride inhibition of fluid absorption. Fluid was added onto the tracheal mucosa to give initial ASL depth ∼20 μm. The ASL was covered with perfluorocarbon, and ASL depth measured at 1 and 2 h. Where indicated, amiloride was added at time 0 to the ASL and serosal perfusate, as done in A (means ± SE, n = 3). *P < 0.05.
Similar articles
- Na+ and Cl- conductances in airway epithelial cells: increased Na+ conductance in cystic fibrosis.
Kunzelmann K, Kathöfer S, Greger R. Kunzelmann K, et al. Pflugers Arch. 1995 Nov;431(1):1-9. doi: 10.1007/BF00374371. Pflugers Arch. 1995. PMID: 8584404 - In situ measurement of airway surface liquid [K+] using a ratioable K+-sensitive fluorescent dye.
Namkung W, Song Y, Mills AD, Padmawar P, Finkbeiner WE, Verkman AS. Namkung W, et al. J Biol Chem. 2009 Jun 5;284(23):15916-26. doi: 10.1074/jbc.M808021200. Epub 2009 Apr 13. J Biol Chem. 2009. PMID: 19364771 Free PMC article. - Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiency.
Woodworth BA. Woodworth BA. Laryngoscope. 2015 Oct;125 Suppl 7(0 7):S1-S13. doi: 10.1002/lary.25335. Epub 2015 May 6. Laryngoscope. 2015. PMID: 25946147 Free PMC article. - ENaC inhibitors and airway re-hydration in cystic fibrosis: state of the art.
Althaus M. Althaus M. Curr Mol Pharmacol. 2013 Mar;6(1):3-12. doi: 10.2174/18744672112059990025. Curr Mol Pharmacol. 2013. PMID: 23547930 Review. - The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease.
Moore PJ, Tarran R. Moore PJ, et al. Expert Opin Ther Targets. 2018 Aug;22(8):687-701. doi: 10.1080/14728222.2018.1501361. Epub 2018 Jul 26. Expert Opin Ther Targets. 2018. PMID: 30028216 Review.
Cited by
- Short Term Exposure of Sheep Tracheal Epithelium to Cigarette Smoke Extract Reduces ENaC Current: A Pilot Study.
Jagirdar RM, Grammatikopoulos A, Ioannou M, Solenov E, Gourgoulianis KI, Hatzoglou C, Giannou AD, Mercanoglu B, Zarogiannis SG. Jagirdar RM, et al. In Vivo. 2024 Sep-Oct;38(5):2294-2299. doi: 10.21873/invivo.13694. In Vivo. 2024. PMID: 39187341 Free PMC article. - Taste Receptor Activation in Tracheal Brush Cells by Denatonium Modulates ENaC Channels via Ca2+, cAMP and ACh.
Hollenhorst MI, Kumar P, Zimmer M, Salah A, Maxeiner S, Elhawy MI, Evers SB, Flockerzi V, Gudermann T, Chubanov V, Boehm U, Krasteva-Christ G. Hollenhorst MI, et al. Cells. 2022 Aug 4;11(15):2411. doi: 10.3390/cells11152411. Cells. 2022. PMID: 35954259 Free PMC article. - An Adverse Outcome Pathway for Decreased Lung Function Focusing on Mechanisms of Impaired Mucociliary Clearance Following Inhalation Exposure.
Luettich K, Sharma M, Yepiskoposyan H, Breheny D, Lowe FJ. Luettich K, et al. Front Toxicol. 2021 Dec 14;3:750254. doi: 10.3389/ftox.2021.750254. eCollection 2021. Front Toxicol. 2021. PMID: 35295103 Free PMC article. - Optimizations of In Vitro Mucus and Cell Culture Models to Better Predict In Vivo Gene Transfer in Pathological Lung Respiratory Airways: Cystic Fibrosis as an Example.
Ghanem R, Laurent V, Roquefort P, Haute T, Ramel S, Le Gall T, Aubry T, Montier T. Ghanem R, et al. Pharmaceutics. 2020 Dec 31;13(1):47. doi: 10.3390/pharmaceutics13010047. Pharmaceutics. 2020. PMID: 33396283 Free PMC article. Review. - Leveraging 3D Model Systems to Understand Viral Interactions with the Respiratory Mucosa.
Iverson E, Kaler L, Agostino EL, Song D, Duncan GA, Scull MA. Iverson E, et al. Viruses. 2020 Dec 11;12(12):1425. doi: 10.3390/v12121425. Viruses. 2020. PMID: 33322395 Free PMC article. Review.
References
- Blouquit S, Regnier A, Dannhoffer L, Fermanian C, Naline E, Boucher R, Chinet T. Ion and fluid transport properties of small airways in cystic fibrosis. Am J Respir Crit Care Med 174: 299– 305, 2006 - PubMed
- Boucher RC. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 58: 157– 170, 2007 - PubMed
- Boucher RC. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 23: 146– 158, 2004 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- EB-00415/EB/NIBIB NIH HHS/United States
- HL-73856/HL/NHLBI NIH HHS/United States
- DK-35124/DK/NIDDK NIH HHS/United States
- EY-13574/EY/NEI NIH HHS/United States
- R01 HL073856/HL/NHLBI NIH HHS/United States
- P30 DK072517/DK/NIDDK NIH HHS/United States
- DK-86125/DK/NIDDK NIH HHS/United States
- DK-72517/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources